FDA data illustrate patients’ experiences with visual and clarity issues with IOLs, according to a retrospective observational analysis published in Journal of Refractive Surgery.
Idan Hecht, MD, of the department of ophthalmology at Mayo Clinic, and colleagues explored data from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database to compare visual symptoms and optical clarity concerns across IOL types.
“Although the MAUDE database does not inform on device usage and therefore cannot provide incidence estimates, the reports can help characterize the nature and patterns